The Mylan UK Healthcare Ltd has recalled all remaining stocks of five batches of Ancotil 2.5 g/250 ml solution for infusion as a precautionary measure.
The company’s announcement come after a product sterility non-compliance event which occurred during a recent inspection at the contract manufacturing site, the Medicines and Healthcare products Regulatory Agency (MHRA) said in its update on Thursday (12).
Ancotil 2.5 g/250 ml Solution for Infusion
Active Pharmaceutical Ingredient: Flucytosine
|Batch Number||Expiry Date||Pack Size||First Distributed|
|113987||02/2021||5||26 July 2019|
|114626||03/2021||5||18 July 2019|
|114711||05/2021||5||22 November 2019|
|115051||05/2021||5||05 December 2019|
|F20CBJ||11/2021||5||23 April 2020|
The healthcare professionals have been suggested to stop supplying the batches immediately and quarantine all stock and return the same to their supplier using supplier’s approved process.